Substituted pyrroles suitable for continuous infusion
US6559164B1 · kind B1 · utility
1Cited by
2References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2000 |
| Grant date | May 6, 2003 |
| Priority date | — |
| Expiry date | Jun 5, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel substituted pyrroles having the formula These compounds and their pharmaceutically acceptable salts are suitable for administration to patients as continuous infusion solution and are useful in the treatment and/or control of cell proliferative disorders, in particular cancer. Also disclosed are pharmaceutical compositions containing the foregoing compounds and methods for the treatment and/or control of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.